anewfaceinhell
Greenlighter
- Joined
- Jun 1, 2011
- Messages
- 2
A "serious accident" in a French clinical test has left a person "brain dead" after a French drug trial went wrong, according to reports.
The test concerned a "cannabis-based painkiller"
Several people are in critical condition, with one in a coma, the BBC reported.
Health Minister Marisol Touraine has said the test subjects were taking an oral medication during a trial in Rennes.
"A serious accident took place," she said.
A statement issued by the French health ministry confirmed that one of the test subjects is 'en état de mort cérébrale', or "brain dead."
According to the French newspaper Ouest France the trial was being carried out by Biotrial, a major clinical trial company with 200 of its 300 staff based in the country.
The company based in Rennes, Brittany but which also has offices in London, Brussels and the US.
The trial has been called off and who volunteers who took the medication are being recalled, she said.
It is unclear how many people have taken part in the trial.
The Paris prosecutors office told AFP news agency it has launched an investigation.
Biotrial says it is to hold a press conference with the health ministry at 1.30pm at Rennes CHU hospital.
Taking part in clinical trials can be highly lucrative and is popular among students seeking to earn a little extra money.
Mishaps are rare, but in 2006 six men were hospitalized in London after a clinical trial where they were given a drug intended to fight auto-immune disease and leukemia.
Source: http://www.telegraph.co.uk/news/wor...ves-one-brain-dead-and-five-hospitalised.html
It seems that Biotrial was testing this drug for a Portuguese company named Bial, according to French newspapers.
We don't know yet what compounds compose this drug and their dosages.